Company Profile
PLUS THERAPEUTICS, Inc. Stock Price, News & Analysis
- Ticker:
- PSTV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
3.87 USD (+6.03%)
Close
Last updated: July 31, 2026
37.7M USD
Market cap
Why the stock is moving
Current closing-price context is not available for PSTV.
Company overview
Business overview
PLUS Therapeutics is an oncology company focused on radiotherapeutics and targeted treatment delivery for cancer. Its story is built around the use of radiation-based approaches to address hard-to-treat tumors.
Geographic Base and Sector Classification
PLUS Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
Business Model Characteristics
The company depends on clinical progress, regulatory steps, and the ability to prove its delivery strategy can improve cancer outcomes. Investors usually track readouts, manufacturing, and financing.
Position Within the Biotechnology Landscape
PLUS Therapeutics occupies a niche radiotherapy position within biotech. The stock is catalyst-sensitive because its value depends on narrow oncology programs and execution.
Future catalysts
PLUS Therapeutics’s catalysts are Rhenium-based oncology programs and any clinical or regulatory update that keeps the platform moving. The company remains highly dependent on proof of concept.
Recent news
- 01
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
Source: PLUS THERAPEUTICS, Inc.
- 02
- 03
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
Source: PLUS THERAPEUTICS, Inc.
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PLUS THERAPEUTICS, Inc. (PSTV)?
PLUS THERAPEUTICS, Inc. (PSTV) most recently closed at 3.87 USD, a +6.03% move versus the previous session.
What is the market cap of PLUS THERAPEUTICS, Inc. (PSTV)?
PLUS THERAPEUTICS, Inc. currently has a market capitalization of 37.7M USD on BioPharmSignal.
What does PLUS THERAPEUTICS, Inc. do?
PLUS Therapeutics is an oncology company focused on radiotherapeutics and targeted treatment delivery for cancer. Its story is built around the use of radiation-based approaches to address hard-to-treat tumors.
On which exchange is PSTV stock listed?
PLUS THERAPEUTICS, Inc. (PSTV) is associated with NASDAQ, United States, Biopharma.
What is Therapeutics?
PLUS Therapeutics’s catalysts are Rhenium-based oncology programs and any clinical or regulatory update that keeps the platform moving.
Which conditions is PLUS THERAPEUTICS, Inc. targeting with Therapeutics?
PLUS THERAPEUTICS, Inc. is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does PLUS THERAPEUTICS, Inc. describe recent progress with Therapeutics?
PLUS Therapeutics’s catalysts are Rhenium-based oncology programs and any clinical or regulatory update that keeps the platform moving.
What is Rhenium-based?
PLUS Therapeutics’s catalysts are Rhenium-based oncology programs and any clinical or regulatory update that keeps the platform moving.